With 46 years of tradition and experience, Hemofarm production has been striving to develop, grow and respond to an increasingly demanding European and global market. These efforts have been confirmed by significant European acknowledgments and certificates  (MCA, CE, PIC...) which is evidence that Hemofarm Group’s current manufacturing plants guarantee the highest level of  its own production and contract manufacture.

Almost all of Hemofarm Group’s pharmaceutical forms are manufactured in its plants in Serbia, Montenegro and the Republic of Srpska.
Whether built in accordance with, or adapted to, cGMP requirements, these plants represent reliable and flexible support in the planning of almost all areas of the company’s market strategy.

The quality assurance system and autonomous sector of quality control and development provides full support for production and represents a guarantee of quality and safety of each finished product as well as during the manufacturing process.

The following forms of medicines are produced:

• solid forms

tablets		2 billion/year
vitamin granules		800 tons/year
pellets		5000 kg/year
capsules		200 million/year
effervescences		100 million/year
dry syrups		12.5 million/year

FACILITIES
• Hemofarm complex in Vršac
• Hemofarm doo factory in Šabac
• Solid Dosage Forms Factory in Banja Luka
• Antibiotics factory in Dubovac

•  liquid forms: 

lyo-vials		30 million/year
infusions		24 million bottles/year
syrups		6 million/year
solutions		10 million/year
ampoules		110 million/year
CAPD bags		1.2 million/year
eye drops		5 million/year

FACILITIES
• Hemofarm complex in Vršac
• Hemofarm doo factory in Šabac
• Hemomont factory in Podgorica

• semi-solid forms:  

ointments, creams and gels		16 million tubes/year
suppositories		16.5 million/year

FACILITIES
• Hemofarm doo factory in Šabac